Immunic Inc. (IMUX) Tops Q3 EPS by 4c

Immunic Inc. (NASDAQ: IMUX) reported Q3 EPS of ($0.51), $0.04 better than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
• Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight